Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05277272 · ClinicalTrials.gov registry record
INTO-HLH: A Disease Registry for Patients With Hemophagocytic Lymphohistiocytosis (HLH)
A clinical trial of Hemophagocytic Lymphohistiocytoses, sponsored by Children's Hospital Medical Center, Cincinnati.
- Recruiting
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT05277272 is a study of Hemophagocytic Lymphohistiocytoses that is actively recruiting participants, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 200 participants, below the 680-participant average among 3 other Hemophagocytic Lymphohistiocytoses trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05277272, a study of Hemophagocytic Lymphohistiocytoses, is actively recruiting participants, sponsored by Children's Hospital Medical Center, Cincinnati.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this observational study is to collect data on the natural history of disease of patients with Hemophagocytic Lymphohistiocytosis (HLH) including diagnosis, treatments, responses, and outcomes.
Conditions Studied
Study Locations (1)
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2021-12-31 |
| Est. Completion | 2027-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05277272
The ClinicalTrials.gov registry entry for NCT05277272 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 680-participant average among 3 other Hemophagocytic Lymphohistiocytoses trials with a reported enrollment target (71% lower). The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hemophagocytic Lymphohistiocytoses appearing as the primary indexed condition, and to 0 interventions.
NCT05277272 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT05277272 about?
NCT05277272 is a clinical study titled "INTO-HLH: A Disease Registry for Patients With Hemophagocytic Lymphohistiocytosis (HLH)". The purpose of this observational study is to collect data on the natural history of disease of patients with Hemophagocytic Lymphohistiocytosis (HLH) including diagnosis, treatments, responses, and outcomes.
What is the current status of trial NCT05277272?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2021-12-31. Estimated completion is 2027-01.
What conditions does trial NCT05277272 study?
This clinical trial studies the following conditions: Hemophagocytic Lymphohistiocytoses.
Who is sponsoring clinical trial NCT05277272?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05277272 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hemophagocytic Lymphohistiocytoses
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Describing Treatment Outcomes and Responses in Lymphoma-associated Hemophagocytic Lymphohistiocytosis
RECRUITING
-
Ruxolitinib With De-Intensified HLH-94 for the Treatment of Hemophagocytic Lymphohistiocytosis (HLH)
RECRUITING · Phase 2
-
Haploidentical Hematopoietic Cell Transplantation Using TCR Alpha/Beta and CD19 Depletion
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.